Related Experiment Video
Updated: Feb 3, 2026

Enrichment of Bruch's Membrane from Human Donor Eyes
Published on: November 15, 2015
Seroprevalence of fourteen human polyomaviruses determined in blood donors
Sergio Kamminga1,2, Els van der Meijden2, Mariet C W Feltkamp2
1Department of Blood-borne Infections, Sanquin Research, Amsterdam, the Netherlands.
Abstract:
The polyomavirus family currently includes thirteen human polyomavirus (HPyV) species. In immunocompromised and elderly persons HPyVs are known to cause disease, such as progressive multifocal leukoencephalopathy (JCPyV), haemorrhagic cystitis and nephropathy (BKPyV), Merkel cell carcinoma (MCPyV), and trichodysplasia spinulosa (TSPyV). Some recently discovered polyomaviruses are of still unknown prevalence and pathogenic potential. Because HPyVs infections persist and might be transferred by blood components to immunocompromised patients, we studied the seroprevalence of fourteen polyomaviruses in adult Dutch blood donors. For most polyomaviruses the observed seroprevalence was high (60-100%), sometimes slightly increasing or decreasing with age. Seroreactivity increased with age for JCPyV, HPyV6 and HPyV7 and decreased for BKPyV and TSPyV. The most recently identified polyomaviruses HPyV12, NJPyV and LIPyV showed low overall seroprevalence (~5%) and low seroreactivity, questioning their human tropism. Altogether, HPyV infections are common in Dutch blood donors, with an average of nine polyomaviruses per subject.
Insights
Human polyomaviruses (HPyVs) are widespread in adult blood donors, with most individuals infected by multiple types. This study assessed seroprevalence of fourteen HPyVs in Dutch blood donors, finding high infection rates for most.
Area of Science:
- Virology
- Immunology
- Public Health
Background:
- The human polyomavirus (HPyV) family comprises thirteen species, with some causing significant diseases in immunocompromised individuals.
- HPyVs establish persistent infections and can be transmitted via blood components, posing a risk to vulnerable patient groups.
- The prevalence and pathogenic potential of recently discovered HPyVs remain largely unknown.
Purpose of the Study:
- To determine the seroprevalence of fourteen HPyVs in adult Dutch blood donors.
- To investigate the association between HPyV seroreactivity and age.
- To assess the prevalence of newly identified HPyVs and evaluate their potential human tropism.
Main Methods:
- Sera from adult Dutch blood donors were tested for antibodies against fourteen HPyV species using serological assays.
- Seroprevalence data were analyzed in relation to donor age.
- Statistical methods were employed to assess trends and significance.
Main Results:
- High seroprevalence (60-100%) was observed for most HPyVs in the study population.
- Age-dependent variations in seroreactivity were noted, with increasing prevalence for JCPyV, HPyV6, and HPyV7, and decreasing prevalence for BKPyV and TSPyV.
- Newly identified HPyVs (HPyV12, NJPyV, LIPyV) exhibited low seroprevalence (~5%), suggesting limited human tropism.
Conclusions:
- HPyV infections are highly prevalent among Dutch blood donors, with individuals commonly infected with multiple HPyV types.
- Age influences the seroprevalence patterns of specific HPyVs.
- Further research is needed to fully understand the clinical significance and transmission dynamics of less common HPyVs.
Related Concept Videos
Determining Order of Reaction
Determination
Determining the pH of Salt Solutions
Rate-Determining Steps
In a multistep reaction mechanism, one of the elementary steps progresses significantly slower than the others. This slowest step is called the rate-limiting step (or rate-determining step). A reaction cannot proceed faster than its slowest step, and hence, the rate-determining step limits the overall reaction rate.
The concept of rate-determining step can be understood from the analogy of a 4-lane freeway with a short-stretch of traffic-bottleneck caused due to...
Experimental Determination of Chemical Formula
Composition of Blood
Formed elements constitute the remaining 45% of the blood volume. These...

